[TVTX] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
24-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -44.71%
YoY- 57.60%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 53,496 54,167 48,487 57,249 68,217 54,617 47,407 8.38%
PBT -69,511 -66,979 -75,919 -51,569 -35,596 -38,963 -53,554 18.97%
Tax 145 53 52 4 43 49 313 -40.10%
NP -69,656 -67,032 -75,971 -51,573 -35,639 -39,012 -53,867 18.67%
Tax Rate - - - - - - - -
Total Cost 123,152 121,199 124,458 108,822 103,856 93,629 101,274 13.91%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -130.21 -123.75 -156.68 -90.09 -52.24 -71.43 -113.63 9.49%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -1.09 -1.05 -1.20 -0.84 -0.59 -0.64 -0.96 8.82%
EPS Diluted -1.09 -1.05 -1.20 -0.84 -0.59 -0.64 -0.96 8.82%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.